FDA Drug Application (019174) for TRANDATE HCT by GLAXOSMITHKLINE

Back to FDA Applications sponsored by GLAXOSMITHKLINE

Application Number019174
Product Number001
FormTABLET;ORAL
Dosage25MG;100MG
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameTRANDATE HCT
Active IngredientHYDROCHLOROTHIAZIDE; LABETALOL HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient HYDROCHLOROTHIAZIDE122
List of drugs with Active Ingredient LABETALOL HYDROCHLORIDE5


Back to FDA Applications sponsored by GLAXOSMITHKLINE